保乳术后同侧乳腺肿瘤复发:重复肿块切除与挽救性乳房切除的结局
该研究纳入2013至2019年间113例保乳术后同侧乳腺肿瘤复发患者,其中72%接受挽救性乳房切除(n=84),28%接受重复肿块切除(n=32,其中13例接受再照射)。中位随访2.5年时,两组第二复发率、无病生存与总生存均无显著差异;作者认为经多学科评估后可考虑对选择性的同侧复发患者行重复肿块切除联合再照射。
要点
- 重复肿块切除联合再照射与挽救性乳房切除在第二局部复发、无病生存和总生存上无显著差异。
- 总体第二复发发生率为8%,挽救性乳房切除组为5%(n=4),重复肿块切除组为16%(n=5)。
- 重复肿块切除联合再照射组(n=13)中仅1例出现第二复发(8%)。
核心结论
- 在中位随访2.5年的短期随访中,对于同侧乳腺肿瘤复发患者,经多学科评估后,可考虑对选择性患者行重复肿块切除联合再照射,其术后并发症发生率低且生存结局相当。
研究设计与样本
- 研究为单中心回顾性研究,2013年至2019年间共识别113例保乳术后同侧乳腺肿瘤复发患者,收集初诊及复发时的患者与肿瘤特征。
- 72%的患者接受挽救性乳房切除(n=84),28%接受重复肿块切除(n=32,其中n=13接受再照射)。
- 评估结局包括第二复发和总生存,并评估同侧乳腺肿瘤复发术后30天和90天的并发症。
主要发现
- 挽救性乳房切除组患者初诊时更年轻(P = .007),且从初诊至同侧乳腺肿瘤复发的时间更长(P = .03)。
- 中位随访2.5年时,第二复发总体发生率为8%,挽救性乳房切除组为5%(n=4),重复肿块切除组为16%(n=5)。
- 在接受重复肿块切除联合再照射的患者(n=13)中,仅1例出现第二复发(8%)。
- 重复肿块切除联合再照射与挽救性乳房切除相比,第二局部复发率(P = .11)、无病生存(P = .13)和总生存(P = .95)均无显著差异。
临床怎么用
- 作者认为,对于同侧乳腺肿瘤复发患者,经多学科评估后,可考虑对选择性患者行重复肿块切除联合再照射。
局限性
- 本文报告为短期随访(中位随访2.5年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We examined the outcomes of salvage mastectomy and repeat lumpectomy for management of ipsilateral breast tumor recurrence. METHODS: Between 2013 and 2019, 113 patients with an ipsilateral breast tumor recurrence after breast conserving surgery were identified. Patients and tumor characteristics at initial diagnosis and at recurrence were collected. Outcomes evaluated included second recurrence and overall survival. Complications at 30-days and 90-days after surgery for ipsilateral breast tumor recurrence were evaluated. RESULTS: Seventy-two percent of patients underwent salvage mastectomy (n = 84) and 28% underwent repeat lumpectomy (n = 32 overall, n = 13 reirradiation). Salvage mastectomy patients were younger at initial diagnosis (P = .007) with longer time to ipsilateral breast tumor recurrence from first diagnosis (P = .03). At 2.5 years median follow-up, the overall incidence of second recurrence was 8% with 5% rate (n = 4) in salvage mastectomy group versus 16% (n = 5) in repeat lumpectomy group; however, among patients undergoing repeat lumpectomy with reirradiation (n = 13), only one patient developed a second recurrence (8%). There was no significant difference in rates of second local recurrence (P = .11), disease free survival (P = .13), or overall survival (P = .95) between repeat lumpectomy with reirradiation and salvage mastectomy. CONCLUSION: At a short-term follow-up, repeat lumpectomy with reirradiation could be considered in a select group of patients presenting with an ipsilateral breast tumor recurrence with multidisciplinary input with low rates of postoperative complications and equivalent survival outcomes.
引用
- ElSherif A, Shah C, Downs-Kelly E, et al. Outcomes of ipsilateral breast tumor recurrence after breast conserving surgery: Repeat lumpectomy as an alternative to salvage mastectomy. Surgery. 2021. PMID: 34911644. doi:10.1016/j.surg.2021.10.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。